TargetMol

BMS-561390

Product Code:
 
TAR-T26851
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26851-5mg5mg£1,010.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26851-50mg50mg£1,982.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26851-100mg100mg£2,560.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
BMS-561390, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.
CAS:
214287-99-7
Formula:
C14H12ClF3N2O
Molecular Weight:
316.71
Purity:
0.98
SMILES:
FC(F)(F)[C@]1(NC(=O)Nc2ccc(Cl)cc12)C=CC1CC1

References

1. Li S, Ma JA. Core-structure-inspired asymmetric addition reactions: enantioselective synthesis of dihydrobenzoxazinone- and dihydroquinazolinone-based anti-HIV agents. Chem Soc Rev. 2015 Nov 7;44(21):7439-48. doi: 10.1039/c5cs00342c. Review. PubMed PMID: 26177889. 2. Bindra DS, Desikan S. Impact of micromeritic properties of an active pharmaceutical ingredient on its compaction behavior. Pharm Dev Technol. 2015 Mar;20(2):129-38. doi: 10.3109/10837450.2013.852569. PubMed PMID: 24219704. 3. Yuan HN, Li S, Nie J, Zheng Y, Ma JA. Highly enantioselective decarboxylative Mannich reaction of malonic acid half oxyesters with cyclic trifluoromethyl ketimines: synthesis of ?-amino esters and anti-HIV drug DPC 083. Chemistry. 2013 Nov 18;19(47):15856-60. doi: 10.1002/chem.201303307. PubMed PMID: 24150893. 4. Yuan HN, Wang S, Nie J, Meng W, Yao Q, Ma JA. Hydrogen-bond-directed enantioselective decarboxylative Mannich reaction of ?-ketoacids with ketimines: application to the synthesis of anti-HIV drug DPC 083. Angew Chem Int Ed Engl. 2013 Apr 2;52(14):3869-73. doi: 10.1002/anie.201210361. PubMed PMID: 23460261.